• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Negative attitudes about medications for opioid use disorder among criminal legal staff.刑事司法工作人员对阿片类物质使用障碍药物的负面态度。
Drug Alcohol Depend Rep. 2022 Apr 25;3:100056. doi: 10.1016/j.dadr.2022.100056. eCollection 2022 Jun.
2
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.一项针对 Veterans Health Administration 中涉及法律问题的退伍军人中阿片类药物使用障碍药物治疗的障碍和促进因素的全国性调查。
Subst Abus. 2022;43(1):556-563. doi: 10.1080/08897077.2021.1975867. Epub 2021 Sep 29.
3
Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.在刑事司法系统中使用药物治疗阿片类药物使用障碍的障碍和促进因素:临床医生的观点。
J Subst Use Addict Treat. 2023 Jun;149:209051. doi: 10.1016/j.josat.2023.209051. Epub 2023 Apr 19.
4
Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.佛罗里达州刑事问题解决法院和依赖法院工作人员对阿片类药物使用障碍药物的信念。
Am J Drug Alcohol Abuse. 2020 Nov 1;46(6):749-760. doi: 10.1080/00952990.2020.1807559. Epub 2020 Sep 24.
5
Whose opinion matters about medications for opioid use disorder? A cross-sectional survey of social norms among court staff.谁的意见对阿片类药物使用障碍的药物治疗重要?一项针对法庭工作人员社会规范的横断面调查。
Subst Abus. 2021;42(4):735-750. doi: 10.1080/08897077.2020.1846666. Epub 2020 Dec 7.
6
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
7
Court personnel attitudes towards medication-assisted treatment: A state-wide survey.法庭工作人员对药物辅助治疗的态度:全州范围的调查。
J Subst Abuse Treat. 2019 Sep;104:72-82. doi: 10.1016/j.jsat.2019.06.011. Epub 2019 Jun 28.
8
"I think we're getting better but we're still not there": Provider-based stigma and perceived barriers to care for people who use opioids (PWUO).“我认为我们正在好转,但仍未达到目标”:基于提供者的耻辱感以及阿片类药物使用者获得护理的感知障碍。
J Subst Use Addict Treat. 2024 Apr;159:209270. doi: 10.1016/j.josat.2023.209270. Epub 2023 Dec 14.
9
Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment.刑事司法系统转介的阿片类药物使用障碍治疗中药物使用的差异。
JAMA Health Forum. 2024 Sep 6;5(9):e242807. doi: 10.1001/jamahealthforum.2024.2807.
10
Knowledge of medications for opioid use disorder and associated stigma among primary care professionals.阿片类药物使用障碍相关药物知识及初级保健专业人员的相关耻辱感。
Ann Med. 2024 Dec;56(1):2399316. doi: 10.1080/07853890.2024.2399316. Epub 2024 Sep 5.

引用本文的文献

1
Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder.运用叙述性和信息性信息来改善惩教专业人员对阿片类药物使用障碍药物治疗的态度。
Health Justice. 2025 Aug 26;13(1):53. doi: 10.1186/s40352-025-00363-3.
2
A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings.对监狱环境中基于提供者的阿片类药物使用障碍(OUD)污名化以及对阿片类药物使用障碍药物治疗(MOUD)支持情况的混合方法探索性评估。
Harm Reduct J. 2025 Aug 18;22(1):141. doi: 10.1186/s12954-025-01291-z.
3
The role of micro-, meso-, and macro-level stigma on the uptake of medications for opioid use disorder (MOUD) among women in the criminal legal system.微观、中观和宏观层面的耻辱感对刑事法律系统中女性使用阿片类药物使用障碍药物(MOUD)的影响。
BMC Womens Health. 2025 Jul 25;25(1):370. doi: 10.1186/s12905-025-03863-4.
4
Overdose education and naloxone distribution among women with a history of OUD transitioning to the community following jail release.对有药物使用障碍史、出狱后过渡到社区的女性进行过量用药教育和纳洛酮发放。
Health Justice. 2025 May 15;13(1):33. doi: 10.1186/s40352-025-00337-5.
5
Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.美国监狱中阿片类药物使用障碍通用药物可及性的障碍
JAMA Netw Open. 2025 Apr 1;8(4):e255340. doi: 10.1001/jamanetworkopen.2025.5340.
6
The importance of contextually specific support relationships in implementing programs to link people to medication for opioid use disorder (MOUD) treatment during reentry from county jails.在从县监狱重新进入社会期间实施将人们与阿片类药物使用障碍(MOUD)治疗药物联系起来的项目时,因地制宜的支持关系的重要性。
Health Justice. 2025 Mar 31;13(1):20. doi: 10.1186/s40352-025-00330-y.
7
Just an unfair score: Perceptions of gender inequity in the treatment of substance use disorders among women involved in the criminal legal system.只是一个不公平的评分:参与刑事法律系统的女性在物质使用障碍治疗中对性别不平等的认知。
J Subst Use Addict Treat. 2025 Feb;169:209587. doi: 10.1016/j.josat.2024.209587. Epub 2024 Nov 29.
8
Overdose Experiences Among a Sample of Women in Jail with Opioid Use Disorder.患有阿片类物质使用障碍的女性囚犯样本中的过量用药经历
Subst Use Misuse. 2024;59(13):1911-1920. doi: 10.1080/10826084.2024.2383982. Epub 2024 Jul 28.
9
Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.对阿片类药物使用障碍药物的态度和培训:青年法律系统和社区心理健康中心员工中的描述性分析。
Subst Abuse Treat Prev Policy. 2024 Jun 21;19(1):32. doi: 10.1186/s13011-024-00614-w.
10
Health equity for people living in correctional facilities: Addressing bias, stigma, and dehumanization.囚犯医疗保健公平性:消除偏见、污名化和非人性化。
Res Nurs Health. 2024 Aug;47(4):359-365. doi: 10.1002/nur.22405. Epub 2024 Jun 15.

本文引用的文献

1
Managing the Concealable Stigma of Criminal Justice System Involvement: A Longitudinal Examination of Anticipated Stigma, Social Withdrawal, and Post-Release Adjustment.应对刑事司法系统涉入带来的隐性污名:对预期污名、社会退缩及释放后调整的纵向考察
J Soc Issues. 2017 Jun;73(2):322-340. doi: 10.1111/josi.12219. Epub 2017 Jun 19.
2
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.舌下丁丙诺啡-纳洛酮与注射用纳曲酮治疗阿片类药物使用障碍的比较:患者特征在指导治疗选择中的潜在作用。
Am J Psychiatry. 2021 Jul;178(7):660-671. doi: 10.1176/appi.ajp.2020.20060816. Epub 2021 Jun 25.
3
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.阿片类激动剂治疗与阿片类药物依赖患者全因死亡率及特定死因的相关性:系统评价和荟萃分析。
JAMA Psychiatry. 2021 Sep 1;78(9):979-993. doi: 10.1001/jamapsychiatry.2021.0976.
4
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.对患者和医疗服务提供者关于阿片类物质使用障碍治疗药物观点的系统评价。
J Subst Abuse Treat. 2020 Dec;119:108146. doi: 10.1016/j.jsat.2020.108146. Epub 2020 Sep 22.
5
Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.佛罗里达州刑事问题解决法院和依赖法院工作人员对阿片类药物使用障碍药物的信念。
Am J Drug Alcohol Abuse. 2020 Nov 1;46(6):749-760. doi: 10.1080/00952990.2020.1807559. Epub 2020 Sep 24.
6
Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System.在刑事司法系统中治疗阿片类药物使用障碍和相关传染病。
Infect Dis Clin North Am. 2020 Sep;34(3):585-603. doi: 10.1016/j.idc.2020.06.012.
7
Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.法律体系内的退伍军人阿片类药物使用障碍药物治疗障碍:定性研究。
J Gen Intern Med. 2020 Sep;35(9):2529-2536. doi: 10.1007/s11606-020-05944-6. Epub 2020 Jun 24.
8
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
9
"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.“在停止使用任何药物之前,你都不算戒毒成功”:阿巴拉契亚农村地区对药物辅助治疗的认知
Int J Drug Policy. 2020 Nov;85:102704. doi: 10.1016/j.drugpo.2020.102704. Epub 2020 Mar 12.
10
Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.评估在美国监狱中广泛采用阿片类药物使用障碍筛查和药物治疗的影响。
Drug Alcohol Depend. 2020 Mar 1;208:107858. doi: 10.1016/j.drugalcdep.2020.107858. Epub 2020 Jan 18.

刑事司法工作人员对阿片类物质使用障碍药物的负面态度。

Negative attitudes about medications for opioid use disorder among criminal legal staff.

作者信息

Moore Kelly E, Siebert Shania L, Kromash Rachelle, Owens Mandy D, Allen Diamond C

机构信息

Department of Psychology, East Tennessee State University, 420 Rogers-Stout Hall P.O. Box 70649, Johnson City, TN 37614, USA.

Addictions, Drug & Alcohol Institute, Department of Psychiatry and Behavioral Sciences, University of Washington, USA.

出版信息

Drug Alcohol Depend Rep. 2022 Apr 25;3:100056. doi: 10.1016/j.dadr.2022.100056. eCollection 2022 Jun.

DOI:10.1016/j.dadr.2022.100056
PMID:36845981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9948914/
Abstract

BACKGROUND

Stigma is a barrier to the treatment of opioid use disorder (OUD) in the criminal legal system. Staff sometimes have negative attitudes about medications for OUD (i.e., MOUD), but there is little research on what drives these attitudes. How staff think about criminal involvement and addiction may explain their attitudes toward MOUD.

METHODS

A convenience sample of U.S. criminal legal staff (e.g., correctional/probation officers, nurses, psychologists, court personnel) were recruited via online methods ( = 152). Participants completed an online survey of their attitudes about justice-involved people and addiction, and these were entered as predictors of an adapted version of the Opinions about Medication Assisted Treatment survey (OAMAT) in a linear regression, controlling for sociodemographics (cross-sectional design).

RESULTS

At the bivariate level, measures capturing more stigmatizing attitudes toward justice-involved people, believing addiction represents a moral weakness, and believing people with addiction are responsible for their actions and their recovery were related to more negative attitudes about MOUD, whereas higher educational attainment and believing addiction has a genetic basis were related to more positive attitudes about MOUD. In a linear regression, only stigma toward justice-involved people significantly predicted negative attitudes about MOUD ( = -.27,  = .010).

CONCLUSION

Criminal legal staff's stigmatizing attitudes about justice-involved people, such as believing they are untrustworthy and cannot be rehabilitated, contributed significantly to negative attitudes about MOUD, above their beliefs about addiction. The stigma tied to criminal involvement needs to be addressed in attempts to increase MOUD adoption in the criminal legal system.

摘要

背景

耻辱感是刑事司法系统中阿片类物质使用障碍(OUD)治疗的一个障碍。工作人员有时对用于治疗OUD的药物(即药物辅助治疗,MOUD)持有消极态度,但对于驱动这些态度的因素,相关研究较少。工作人员对犯罪与成瘾的看法可能解释了他们对MOUD的态度。

方法

通过在线方式招募了美国刑事司法工作人员的便利样本(如惩教/缓刑官员、护士、心理学家、法庭工作人员)(n = 152)。参与者完成了一项关于他们对涉司法人员和成瘾的态度的在线调查,并将这些作为药物辅助治疗意见调查(OAMAT)改编版的预测因素纳入线性回归分析,同时控制社会人口统计学因素(横断面设计)。

结果

在双变量水平上,对涉司法人员持有更多耻辱态度的测量指标、认为成瘾代表道德弱点、认为成瘾者应对自己的行为及其康复负责,这些都与对MOUD的更消极态度相关,而较高的教育程度和认为成瘾有遗传基础则与对MOUD的更积极态度相关。在线性回归分析中,只有对涉司法人员的耻辱感显著预测了对MOUD的消极态度(β = -0.27,p = 0.010)。

结论

刑事司法工作人员对涉司法人员的耻辱态度,如认为他们不可信且无法改过自新,在很大程度上导致了对MOUD的消极态度,这超过了他们对成瘾的看法。在刑事司法系统中增加MOUD的采用率的尝试中,需要解决与犯罪相关的耻辱感问题。